{"id":3928,"date":"2016-03-08T08:02:58","date_gmt":"2016-03-08T07:02:58","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/"},"modified":"2020-06-26T14:32:21","modified_gmt":"2020-06-26T12:32:21","slug":"positiva-resultat-i-djurstudie","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/positiva-resultat-i-djurstudie\/","title":{"rendered":"Positiva resultat i djurstudie"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/p>\n<p><span><em>Nanexas drug delivery-system PharmaShell<\/em><em>\u00ae <\/em><em>har i bolagets f\u00f6rsta djurstudie visat sig v\u00e4sentligt kunna p\u00e5verka b\u00e5de halveringstid och maximal koncentration av l\u00e4kemedel. Resultaten \u00e4r viktiga i diskussioner med potentiella partners.<\/em><\/span><\/p>\n<p><\/strong><\/div>\n<p><span>Nanexa har i egen regi genomf\u00f6rt sin f\u00f6rsta djurstudie i r\u00e5tta f\u00f6r att unders\u00f6ka funktionen hos drug delivery-systemet PharmaShell\u00ae. Denna studie har genomf\u00f6rts f\u00f6r att p\u00e5visa m\u00f6jligheten att anv\u00e4nda PharmaShell\u00aesom dep\u00e5beredning, d.v.s. att f\u00f6rl\u00e4nga tiden under vilken l\u00e4kemedel fris\u00e4tts i kroppen.<\/span><\/p>\n<p><span>Resultaten visar tydligt att den s\u00e5 kallade halveringstiden p\u00e5verkas. Fr\u00e5n en halveringstid p\u00e5 1,4 timmar f\u00f6r en beredning utan PharmaShell\u00aetill 52 timmar f\u00f6r en beredning med PharmaShell\u00aei samma dos. M\u00e4tbara niv\u00e5er av l\u00e4kemedlet kunde fortfarande p\u00e5visas i blodplasma efter 6 dygn f\u00f6r beredningen med PharmaShell\u00ae. Det ska j\u00e4mf\u00f6ras med att icke detekterbara niv\u00e5er n\u00e5ddes redan efter ett dygn f\u00f6r beredningen utan PharmaShell\u00ae.<\/span><\/p>\n<p><span>En ytterligare effekt som studien p\u00e5visade var att den maximala koncentrationen i blodplasma kunde begr\u00e4nsas kraftigt; fr\u00e5n 25 ng\/ml till 6 ng\/ml, vilket \u00e4r positivt f\u00f6r en dep\u00e5beredning eftersom det kan reducera risken f\u00f6r biverkningar.<\/span><\/p>\n<p><span>Djurstudiens resultat visar tydligt p\u00e5 PharmaShells\u00ae effekter och breda anv\u00e4ndningsomr\u00e5de och \u00e4r viktiga i diskussioner med potentiella partners.<\/span><\/p>\n<p><span>Bolagets VD David Westberg kommenterar: \u201dVi \u00e4r f\u00f6rst\u00e5s mycket glada \u00f6ver djurstudiens positiva resultat. Vi ser detta som ett viktigt steg i att dokumentera en bred anv\u00e4ndning av PharmaShell\u00aesom en kommande v\u00e4rdefull drug delivery-plattform f\u00f6r utveckling av morgondagens l\u00e4kemedel.\u201d<\/span><\/p>\n<p><span>F\u00f6r mer information kontakta:<br \/>David Westberg \u2013 VD, Nanexa AB (publ) <br \/>?Telefon: 0709 -42 83 03?<br \/>E-post:\u00a0<a href=\"http:\/\/www.nanexa.se\/\" rel=\"nofollow\">david.westberg@nanexa.se<br \/>www.nanexa.se<\/a><\/span><\/p>\n<p><span>Om Nanexa AB (publ)<\/span><\/p>\n<p><span>Nanexa AB \u00e4r ett h\u00f6gteknologiskt forskningsf\u00f6retag som utvecklar och marknadsf\u00f6r produkter inom nanoteknologi. Bolagets fokus ligger p\u00e5 PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal omr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra AstraZeneca och Karolinska Institutet.<\/span><\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/aktietorget.blob.core.windows.net\/press\/news\/nanexa\/77261\/485958.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nanexas drug delivery-system PharmaShell \u00ae har i bolagets f\u00f6rsta djurstudie visat sig v\u00e4sentligt kunna p\u00e5verka b\u00e5de halveringstid och maximal koncentration av l\u00e4kemedel. Resultaten \u00e4r viktiga i diskussioner med potentiella partners.<\/p>\n","protected":false},"template":"","class_list":["post-3928","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Positiva resultat i djurstudie - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Positiva resultat i djurstudie - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexas drug delivery-system PharmaShell \u00ae har i bolagets f\u00f6rsta djurstudie visat sig v\u00e4sentligt kunna p\u00e5verka b\u00e5de halveringstid och maximal koncentration av l\u00e4kemedel. Resultaten \u00e4r viktiga i diskussioner med potentiella partners.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-26T12:32:21+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiva-resultat-i-djurstudie\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiva-resultat-i-djurstudie\\\/\",\"name\":\"Positiva resultat i djurstudie - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2016-03-08T07:02:58+00:00\",\"dateModified\":\"2020-06-26T12:32:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiva-resultat-i-djurstudie\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiva-resultat-i-djurstudie\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/positiva-resultat-i-djurstudie\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Positiva resultat i djurstudie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Positiva resultat i djurstudie - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/","og_locale":"sv_SE","og_type":"article","og_title":"Positiva resultat i djurstudie - Nanexa AB","og_description":"Nanexas drug delivery-system PharmaShell \u00ae har i bolagets f\u00f6rsta djurstudie visat sig v\u00e4sentligt kunna p\u00e5verka b\u00e5de halveringstid och maximal koncentration av l\u00e4kemedel. Resultaten \u00e4r viktiga i diskussioner med potentiella partners.","og_url":"https:\/\/nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/","og_site_name":"Nanexa AB","article_modified_time":"2020-06-26T12:32:21+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/","url":"https:\/\/nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/","name":"Positiva resultat i djurstudie - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2016-03-08T07:02:58+00:00","dateModified":"2020-06-26T12:32:21+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/positiva-resultat-i-djurstudie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Positiva resultat i djurstudie"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}